共 5 条
[1]
Duffin KC, 2017, J DRUGS DERMATOL, V16, P147
[2]
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
[J].
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY,
2015, 73 (01)
:37-49
[4]
Strober B, 2017, 75 ANN M AM AC DERM